Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US2561352038

SecurityRDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
InstitutionGreenleaf Trust
Latest Disclosed Ownership122,795 shares
Latest Disclosed Value $ 1,700,711
Greenleaf Trust reports 0.50% increase in ownership of RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)

On April 27, 2026 - Greenleaf Trust filed a 13F-HR form disclosing ownership of 122,795 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) (US:RDY) valued at $1,700,711 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 122,184 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock). This represents a change in shares of 0.50% during the quarter. The current value of the position is $1,598,791 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 Com 256135203 122,795 611 0.50 1,701 -0.87 0.0094
2026-01-21 2025-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 Com 256135203 122,184 3,769 3.18 1,715 3.63 0.0157
2025-10-22 2025-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 Com 256135203 118,415 -54 -0.05 1,655 -7.02 0.0150
2025-07-17 2025-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 Com 256135203 118,469 1,028 0.88 1,781 14.91 0.0157
2025-04-30 2025-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 Com 256135203 117,441 -170 -0.14 1,549 -16.59 0.0141
2025-01-24 2024-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 117,611 94,113 400.51 1,857 -0.48 0.0169
2024-10-22 2024-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,498 0 0.00 1,867 4.25 0.0166
2024-07-22 2024-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,498 10 0.04 1,790 3.95 0.0170
2024-04-29 2024-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,488 58 0.25 1,723 5.64 0.0160
2024-01-31 2023-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,430 -69 -0.29 1,630 3.76 0.0175
2023-11-09 2023-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,499 -290 -1.22 1,571 4.66 0.0181
2023-08-09 2023-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,789 51 0.21 1,501 11.10 0.0160
2023-05-11 2023-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,738 -58 -0.24 1,351 135,000.00 0.0153
2023-01-25 2022-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,796 93 0.39 1 -99.92 0.0156
2022-11-10 2022-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,703 44 0.19 1,241 -5.27 0.0184
2022-08-12 2022-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 23,659 -1,757 -6.91 1,310 -7.49 0.0198
2022-04-27 2022-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 25,416 -2,546 -9.11 1,416 -22.58 0.0169
2022-02-11 2021-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 27,962 3,360 13.66 1,829 14.10 0.0214
2021-11-12 2021-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 24,602 -374 -1.50 1,603 -12.69 0.0195
2021-08-10 2021-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 24,976 -26 -0.10 1,836 19.61 0.0228
2021-04-30 2021-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 25,002 0 0.00 1,535 -13.86 0.0203
2021-02-08 2020-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 25,002 -150 -0.60 1,782 1.83 0.0237
2020-10-30 2020-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 25,152 245 0.98 1,750 32.58 0.0271
2020-08-12 2020-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 24,907 172 0.70 1,320 32.26 0.0231
2020-04-29 2020-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 24,735 8,316 50.65 998 49.85 0.0198
2020-02-11 2019-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 16,419 7,848 91.56 666 104.92 0.0104
2019-11-08 2019-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 8,571 59 0.69 325 1.88 0.0050
2019-07-24 2019-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 8,512 329 4.02 319 -3.63 0.0050
2019-05-08 2019-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 8,183 -2,766 -25.26 331 -19.85 0.0055
2019-02-07 2018-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 10,949 2,570 30.67 413 42.41 0.0082
2018-10-29 2018-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 8,379 1,671 24.91 290 34.26 0.0052
2018-08-07 2018-06-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 6,708 -7,051 -51.25 216 -52.00 0.0041
2018-04-30 2018-03-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 13,759 1,246 9.96 450 -4.26 0.0089
2018-02-08 2017-12-31 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 12,513 -1,154 -8.44 470 -3.69 0.0095
2017-11-13 2017-09-30 13F Dr Reddys Lab Ltd ADR Repstg 1 ADR 256135203 13,667 13,667 488 0.0107
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.